Protagonist Therapeutics, Inc (PTGX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2014: -$9.32M2015: -$14.79M2016: -$32.67M2017: -$37.90M2018: -$42.27M2019: -$80.52M2020: -$64.52M2021: -$125.84M2022: -$131.37M2023: -$93.65M2024: $252.84M2025: -$158.13M-$158.13M
2014Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$158.13M-162.5%
2024$252.84M+370.0%
2023-$93.65M+28.7%
2022-$131.37M-4.4%
2021-$125.84M-95.1%
2020-$64.52M+19.9%
2019-$80.52M-90.5%
2018-$42.27M-11.5%
2017-$37.90M-16.0%
2016-$32.67M-120.8%
2015-$14.79M-58.8%
2014-$9.32M